First Trust Nasdaq Pharmaceuticals ETF (FTXH)
$40.73
▼ -0.09 (-0.22%)
1-day change
$28.77 – $43.52
52-week range
Holdings data is not available for this fund yet.
FTXH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -3.32% | ▼ -3.29% |
| 3M | ▲ +17.81% | ▲ +18.35% |
| 6M | ▲ +17.81% | ▲ +18.35% |
| YTD | ▲ +23.65% | ▲ +24.22% |
| 1Y | ▲ +37.92% | ▲ +39.10% |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +43.72% | ▲ +49.11% |
Volatility 1Y25.17%
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*2.29
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jun 2026)
-$1.8M
Quarter ending Jun 2026
+$3.3M
Trailing 12 months
+$13.4M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 51 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| ELI LILLY & COMPANY | 532457108 | $2.8M | 7.77 | 2,347 | EC | US |
| ABBVIE INC | 00287Y109 | $2.7M | 7.39 | 10,640 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $2.6M | 7.07 | 19,942 | EC | US |
| JOHNSON & JOHNSON | 478160104 | $2.5M | 6.96 | 9,939 | EC | US |
| BRISTOL-MYERS SQUIBB COMPANY | 110122108 | $2.3M | 6.29 | 39,590 | EC | US |
| BIOGEN INC | 09062X103 | $1.4M | 3.84 | 6,436 | EC | US |
| VIATRIS INC | 92556V106 | $1.3M | 3.62 | 82,694 | EC | US |
| CARDINAL HEALTH INC | 14149Y108 | $1.3M | 3.53 | 5,386 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $1.2M | 3.41 | 2,485 | EC | US |
| AMGEN INC | 031162100 | $1.2M | 3.18 | 3,181 | EC | US |
| PFIZER INC | 717081103 | $1.1M | 2.97 | 44,652 | EC | US |
| GILEAD SCIENCES INC | 375558103 | $1.0M | 2.89 | 8,289 | EC | US |
| UNITED THERAPEUTICS CORP | 91307C102 | $987K | 2.72 | 1,822 | EC | US |
| REGENERON PHARMACEUTICALS INC | 75886F107 | $985K | 2.72 | 1,579 | EC | US |
| JAZZ PHARMACEUTICALS PLC | · | $901K | 2.49 | 3,741 | EC | IE |
| INCYTE CORP | 45337C102 | $867K | 2.39 | 7,648 | EC | US |
| ILLUMINA INC | 452327109 | $719K | 1.98 | 4,088 | EC | US |
| ZOETIS INC | 98978V103 | $677K | 1.87 | 9,417 | EC | US |
| EXELIXIS INC | 30161Q104 | $625K | 1.72 | 11,488 | EC | US |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | 159864107 | $539K | 1.49 | 2,377 | EC | US |
| MEDPACE HOLDINGS INC | 58506Q109 | $512K | 1.41 | 966 | EC | US |
| PTC THERAPEUTICS INC | 69366J200 | $497K | 1.37 | 6,091 | EC | US |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | $495K | 1.37 | 2,939 | EC | US |
| ALKERMES PLC | · | $491K | 1.35 | 9,366 | EC | IE |
| HALOZYME THERAPEUTICS INC | 40637H109 | $438K | 1.21 | 5,593 | EC | US |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | $404K | 1.11 | 7,061 | EC | US |
| TWIST BIOSCIENCE CORP | 90184D100 | $372K | 1.03 | 3,619 | EC | US |
| SPYRE THERAPEUTICS INC | 00773J202 | $351K | 0.97 | 3,948 | EC | US |
| TRAVERE THERAPEUTICS INC | 89422G107 | $324K | 0.89 | 5,700 | EC | US |
| TG THERAPEUTICS INC | 88322Q108 | $310K | 0.86 | 5,643 | EC | US |
| ELANCO ANIMAL HEALTH INC | 28414H103 | $300K | 0.83 | 12,210 | EC | US |
| 10X GENOMICS INC | 88025U109 | $282K | 0.78 | 7,367 | EC | US |
| GUARDANT HEALTH INC | 40131M109 | $271K | 0.75 | 1,808 | EC | US |
| LIGAND PHARMACEUTICALS INC | 53220K504 | $271K | 0.75 | 856 | EC | US |
| ARCUS BIOSCIENCES INC | 03969F109 | $257K | 0.71 | 8,336 | EC | US |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | $251K | 0.69 | 14,511 | EC | US |
| ARROWHEAD PHARMACEUTICALS INC | 04280A100 | $238K | 0.66 | 2,918 | EC | US |
| CATALYST PHARMACEUTICALS INC | 14888U101 | $231K | 0.64 | 7,357 | EC | US |
| KRYSTAL BIOTECH INC | 501147102 | $229K | 0.63 | 616 | EC | US |
| PROTAGONIST THERAPEUTICS INC | 74366E102 | $226K | 0.62 | 1,844 | EC | US |
| MODERNA INC | 60770K107 | $222K | 0.61 | 3,170 | EC | US |
| MIRUM PHARMACEUTICALS INC | 604749101 | $215K | 0.59 | 1,840 | EC | US |
| KYMERA THERAPEUTICS INC | 501575104 | $213K | 0.59 | 1,859 | EC | US |
| ROIVANT SCIENCES LTD | · | $208K | 0.57 | 5,868 | EC | BM |
| ACADIA PHARMACEUTICALS INC | 004225108 | $175K | 0.48 | 6,914 | EC | US |
| IONIS PHARMACEUTICALS INC | 462222100 | $166K | 0.46 | 2,093 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $165K | 0.46 | 6,296 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $154K | 0.42 | 510 | EC | US |
| SUPERNUS PHARMACEUTICALS INC | 868459108 | $144K | 0.40 | 3,103 | EC | US |
| TARSUS PHARMACEUTICALS INC | 87650L103 | $142K | 0.39 | 2,249 | EC | US |
Dividends 39 payments
0.71%TTM yield
$0.29TTM payout / share
Quarterly
(est.)
| Ex-date | Amount / share |
|---|---|
| Sept. 24, 2026 | $0.0110 |
| June 25, 2026 | $0.0920 |
| March 26, 2026 | $0.0570 |
| Dec. 12, 2025 | $0.1290 |
| Sept. 25, 2025 | $0.1450 |
| June 26, 2025 | $0.0890 |
| March 27, 2025 | $0.0990 |
| Dec. 13, 2024 | $0.1300 |
| Sept. 26, 2024 | $0.1220 |
| June 27, 2024 | $0.1280 |
| March 21, 2024 | $0.0680 |
| Dec. 22, 2023 | $0.1230 |
| Sept. 22, 2023 | $0.0730 |
| June 27, 2023 | $0.1180 |
| March 24, 2023 | $0.1000 |
| Dec. 23, 2022 | $0.1250 |
| Sept. 23, 2022 | $0.0910 |
| June 24, 2022 | $0.0380 |
| March 25, 2022 | $0.0490 |
| Dec. 23, 2021 | $0.1100 |
| Sept. 23, 2021 | $0.0390 |
| June 24, 2021 | $0.0530 |
| March 25, 2021 | $0.0770 |
| Dec. 24, 2020 | $0.0640 |
| Sept. 24, 2020 | $0.0430 |
| June 25, 2020 | $0.0460 |
| March 26, 2020 | $0.0590 |
| Dec. 13, 2019 | $0.0410 |
| Sept. 25, 2019 | $0.0500 |
| June 14, 2019 | $0.0400 |
| March 21, 2019 | $0.0260 |
| Dec. 18, 2018 | $0.0370 |
| Sept. 14, 2018 | $0.0260 |
| June 21, 2018 | $0.0350 |
| March 22, 2018 | $0.0780 |
| Sept. 21, 2017 | $0.3800 |
| June 22, 2017 | $0.0550 |
| March 23, 2017 | $0.0310 |
| Dec. 21, 2016 | $0.0340 |
Institutional owners (13F) 30 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| LPL Financial LLC | $5,784,616 | 25.32% | 151,471 | Shares | June 30, 2026 |
| OPPENHEIMER & CO INC | $4,360,615 | 19.08% | 114,183 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $2,099,211 | 9.19% | 54,968 | Shares | June 30, 2026 |
| TRUIST FINANCIAL CORP | $1,990,662 | 8.71% | 52,126 | Shares | June 30, 2026 |
| MARSHALL INVESTMENT MANAGEMENT, LLC | $1,454,249 | 6.36% | 38,080 | Shares | June 30, 2026 |
| Ameritas Investment Partners, Inc. | $1,297,935 | 5.68% | 33,987 | Shares | June 30, 2026 |
| Nilsine Partners, LLC | $1,071,488 | 4.69% | 28,057 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $547,000 | 2.39% | 14,322 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $524,345 | 2.29% | 13,730 | Shares | June 30, 2026 |
| DEBUSSY CAPITAL MANAGEMENT LP | $432,560 | 1.89% | 12,590 | Shares | March 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $409,910 | 1.79% | 10,734 | Shares | June 30, 2026 |
| OneDigital Investment Advisors LLC | $356,119 | 1.56% | 9,325 | Shares | June 30, 2026 |
| Sound Income Strategies, LLC | $329,463 | 1.44% | 8,627 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $318,504 | 1.39% | 8,340 | Shares | June 30, 2026 |
| Stratos Wealth Partners, LTD. | $312,392 | 1.37% | 8,180 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $260,530 | 1.14% | 6,822 | Shares | June 30, 2026 |
| BETO FINANCIAL GROUP, LLC | $259,848 | 1.14% | 6,833 | Shares | June 30, 2026 |
| MORGAN STANLEY | $225,984 | 0.99% | 5,917 | Shares | June 30, 2026 |
| FLAGSHIP HARBOR ADVISORS, LLC | $215,085 | 0.94% | 5,632 | Shares | June 30, 2026 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $168,499 | 0.74% | 4,421 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $165,208 | 0.72% | 4,326 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $97,642 | 0.43% | 2,556 | Shares | June 30, 2026 |
| LANARK FINANCIAL, INC. | $44,376 | 0.19% | 1,162 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $39,946 | 0.17% | 1,046 | Shares | June 30, 2026 |
| HARBOUR INVESTMENTS, INC. | $35,478 | 0.16% | 929 | Shares | June 30, 2026 |
| Asset Dedication, LLC | $22,647 | 0.10% | 593 | Shares | June 30, 2026 |
| Capital Investment Advisory Services, LLC | $17,185 | 0.08% | 450 | Shares | June 30, 2026 |
| Princeton Global Asset Management LLC | $5,728 | 0.03% | 150 | Shares | June 30, 2026 |
| Cambridge Investment Research Advisors, Inc. | $1,166 | 0.01% | 30,525 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $52 | 0.00% | 1 | Shares | June 30, 2026 |